Lily Chafetz, MS

Senior Analyst - HEOR
STATLOG Inc, Canada

Poster(s):

• (68) Healthcare resource utilization and costs in patients with multiple sclerosis treated with ofatumumab vs ocrelizumab
  Wednesday, October 29, 2025